Skip to main content
BRAIN Biotech AG logo

BRAIN Biotech AG — Investor Relations & Filings

Ticker · BNN ISIN · DE0005203947 LEI · 391200JKPVHLD6JLZ107 F Professional, scientific and technical activities
Filings indexed 368 across all filing types
Latest filing 2016-05-24 Report Publication Anno…
Country DE Germany
Listing F BNN

About BRAIN Biotech AG

https://www.brain-biotech.com/

BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2016
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2396 characters) dated May 24, 2016, titled 'Preliminary announcement of the publication of financial reports'. It explicitly states that various financial reports (Annual financial report, Group Annual financial report, Group Financial report (half-year/Q2)) *shall be disclosed* on future dates (May 31, 2016, and December 20, 2016) and provides links to where they will be published. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the future publication of reports is classified as a Report Publication Announcement (RPA).
2016-05-24 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2015 bis zum 31.03.2016
Report Publication Announcement Classification · 100% confidence The document is a short notification (849 characters) informing stakeholders that a half-year financial report has been published and providing a link to access it. According to the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2016-05-24 German
Datum:24.05.2016
Report Publication Announcement Classification · 100% confidence The document is a short notification (830 characters) informing shareholders that the Annual Financial Report for the period 01.10.2015 to 30.09.2016 is available on the company's website. It does not contain the report itself, but rather acts as a notice of publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2016-05-24 German
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN and Sudzucker cooperate in the field of CO2 utilisation by microorganisms
Regulatory Filings Classification · 100% confidence The document is a press release dated April 13, 2016, announcing a cooperation between BRAIN AG and Südzucker AG regarding CO2 utilization. It is explicitly labeled as a 'PRESSEINFORMATION' and distributed via 'DGAP-News'. This type of announcement, detailing operational news, partnerships, or strategic updates that are not mandatory financial reports (like 10-K, IR, or ER), typically falls under general regulatory news or corporate announcements. Since it is not a specific financial report, management change, dividend notice, or shareholder vote result, the most appropriate general category for a corporate news release distributed via a regulatory service (DGAP) that doesn't fit other specific codes is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous regulatory announcements.
2016-04-13 German
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN IPO: End of the stabilisation period and exercise of the Greenshoe Option
Capital/Financing Update Classification · 95% confidence The document is a news release disseminated via DGAP (a service often used for regulatory announcements in Germany) concerning the conclusion of the stabilization period and the exercise of the Greenshoe Option following an Initial Public Offering (IPO). This event relates directly to the placement and allocation of shares during a capital market transaction. While it discusses the outcome of the IPO, it is not the primary prospectus or a comprehensive annual/interim report. It is a specific announcement regarding capital structure/share placement following a financing event. This fits best under Capital/Financing Update (CAP) as it finalizes the share placement aspect of the IPO, or potentially Regulatory Filings (RNS) as a general corporate action announcement. Given the specific nature related to share placement and capital structure finalization post-IPO, CAP is a strong fit, but since it's a general news release about the finalization of the offering mechanics, RNS (Regulatory Filings/General Announcement) is often the appropriate category for such specific, non-standardized corporate actions announced via news wire services, especially when the core event (the IPO itself) is concluded. However, since the content is entirely focused on the finalization of the share placement (Greenshoe exercise, free float change), it is fundamentally a capital/financing update. I will classify it as CAP as it directly addresses the final placement of shares from the financing event.
2016-03-10 English
B.R.A.I.N. Biotechnology Research And Information Network AG: NatLifE 2020 Strategic Alliance Given Go-Ahead After Successful Interim Review
M&A Activity Classification · 99% confidence The document is a press release disseminated via DGAP-News, announcing that the 'NatLifE 2020 Strategic Alliance' has been given the go-ahead for its second phase following a successful interim review. It details project progress, new partners joining, and future timelines. This type of announcement, which communicates a specific corporate event or operational update (not a mandatory periodic financial report like 10-K or IR, nor a formal voting result or management change), fits best under the general category for regulatory announcements or news releases that don't fit elsewhere. Since it is a specific news item about an alliance review and continuation, and not a standard financial report, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news releases distributed through official channels like DGAP.
2016-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.